Innovative Drug Development in the Context of FDA Regulation

Overview:

The author describes what the pharmaceutical industry and FDA need to do to escape the current crisis of public confidence.

Author: John E. Calfee, American Enterprise Institute

Find more white papers on cGMPs and ComplianceIndustry Developments

View all white papers»